+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Esomeprazole Magnesium Enteric-coated Tablets Market by Application, Distribution Channel, Route of Administration, Dosage Strength, Dosage Form - Global Forecast 2025-2030- Product Image
Esomeprazole Magnesium Enteric-coated Tablets Market by Application, Distribution Channel, Route of Administration, Dosage Strength, Dosage Form - Global Forecast 2025-2030- Product Image
New

Esomeprazole Magnesium Enteric-coated Tablets Market by Application, Distribution Channel, Route of Administration, Dosage Strength, Dosage Form - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6141095
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The pharmaceutical industry is experiencing unprecedented shifts driven by evolving patient needs, regulatory developments, and advances in drug formulation. Within this dynamic environment, esomeprazole magnesium enteric-coated tablets have emerged as a cornerstone therapy for acid-related disorders. By protecting the active molecule from gastric degradation and ensuring targeted release in the intestine, this delivery format optimizes therapeutic efficacy and patient adherence.

As demographic trends accelerate the prevalence of gastroesophageal reflux and ulcerative conditions, healthcare providers are seeking solutions that balance effectiveness with safety. While generic competition intensifies, manufacturers are investing in process innovation, advanced excipients, and enhanced supply chain resilience. This introduction establishes the foundational context for a comprehensive exploration of market drivers, disruptive trends, regulatory challenges, and strategic imperatives that define the esomeprazole magnesium enteric-coated tablets landscape.

Examining Transformative Shifts Shaping the Esomeprazole Magnesium Tablets Landscape and Redefining Competitive Strategies Across the Healthcare Sector

Emerging from a history of broad proton pump inhibitor utilization, the esomeprazole magnesium segment is now being reshaped by innovation in patient-centric care and digital therapeutics integration. Formulation breakthroughs such as multiparticulate beads and pH-sensitive polymers are enhancing release profiles, while connected devices and digital adherence tools are improving real-world outcomes through remote monitoring.

Concurrently, regulatory authorities are emphasizing high-quality manufacturing protocols and stringent excipient sourcing standards, prompting companies to adopt advanced analytics and real-time quality control solutions. These transformative shifts foster a more collaborative ecosystem, where cross-sector partnerships between pharmaceutical firms, technology providers, and healthcare institutions accelerate the development of next-generation treatment paradigms.

Assessing the Multifaceted Cumulative Impact of United States Tariffs on the Esomeprazole Magnesium Enteric-Coated Tablets Market in 2025 and Beyond

In 2025, the ripple effects of tariff adjustments on active pharmaceutical ingredients and excipient imports are reshaping cost structures and supply chain architectures. Escalating duties on key intermediates have prompted manufacturers to reevaluate geographic sourcing, with some relocating fermentation and synthesis facilities to tariff-exempt jurisdictions.

As firms navigate this new trade environment, they are investing in dual-sourcing strategies and long-term supplier agreements to mitigate volatility. Coupled with strategic inventory management and collaborative forecasting with raw material providers, these efforts aim to preserve margin stability and ensure uninterrupted production. Ultimately, the cumulative impact of these tariff measures is driving a profound reconfiguration of global manufacturing footprints and procurement practices.

Key Segmentation Insights Revealing Application Distribution Channel Administration Route Dosage Strength and Form Patterns Driving the Esomeprazole Magnesium Tablets Market

Analysis of application segmentation underscores the prevalence of gastroesophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome as primary therapeutic areas. Within reflux management, the distinction between erosive and non-erosive profiles informs both dosing strategies and clinical monitoring protocols, while duodenal and gastric ulcer subtypes dictate tailored treatment durations and follow-up regimens.

The distribution landscape reveals distinct channels that complement one another. Hospital pharmacy environments, spanning private and public institutions, cater to acute-care administration and inpatient regimens. Digital distribution via e-commerce platforms and telepharmacy is expanding patient access and adherence support, while traditional chain and independent retail pharmacies remain pivotal for outpatient management. Administration route segmentation balances oral regimens for chronic therapy with intravenous delivery for rapid symptom control. Dosage strength variation from 10 mg to 40 mg enables finely tuned therapeutic interventions, and the choice between capsule and tablet dosage forms addresses manufacturing efficiencies, packaging considerations, and patient preference. This multilayered segmentation framework illuminates critical pathways for targeted investment and operational optimization.

In-Depth Regional Analysis Highlighting Americas Europe Middle East and Africa and Asia-Pacific Dynamics Within the Esomeprazole Magnesium Tablets Market

Regional dynamics reflect diverse maturity levels and growth trajectories. In the Americas, established healthcare infrastructures, supportive reimbursement models, and high incidence of reflux disorders drive robust consumption, with stakeholders emphasizing cost containment and patient support programs to sustain affordability.

Within Europe, the Middle East, and Africa, regulatory harmonization efforts and rising healthcare expenditure are enabling wider adoption of enteric-coated formulations. Meanwhile, Asia-Pacific is characterized by rapidly expanding patient populations, increasing physician awareness, and evolving retail networks that integrate digital solutions. These regional nuances underscore the importance of tailored strategies in market entry, channel development, and stakeholder engagement.

Critical Competitive Landscape and Key Company Strategies Shaping Innovation Portfolio Expansion and Market Positioning in the Esomeprazole Magnesium Tablets Sector

Competitive intensity within the esomeprazole magnesium enteric-coated tablets sector continues to escalate as both originator and generic players vie for market leadership. Established innovators are reinforcing their portfolios through lifecycle management initiatives, patent extensions on novel formulations, and collaborative research agreements focused on incremental therapeutic improvements.

Meanwhile, specialized generic manufacturers are leveraging large-scale production facilities and cost-efficient processes to capture volume segments. Strategic partnerships with contract development and manufacturing organizations expand capacity and facilitate rapid scale-up. Collectively, these companies are deploying differentiated value propositions-ranging from patient support services to bundled delivery solutions-to secure formulary placements and strengthen brand loyalty.

Actionable Recommendations for Industry Leaders to Enhance Market Positioning Optimize Supply Chains and Drive Sustainable Growth in the Esomeprazole Magnesium Tablets Market

To strengthen market positioning, industry leaders should prioritize vertical integration of critical supply chain nodes, including upstream API production and downstream distribution logistics. By fostering transparent relationships with raw material suppliers and third-party logistics providers, companies can enhance traceability, minimize lead times, and reduce exposure to external shocks.

Investing in digital health platforms and telepharmacy capabilities will unlock new patient engagement models and adherence monitoring frameworks. Concurrently, cross-functional teams should collaborate on value-based contracting initiatives with payers, emphasizing outcomes-driven reimbursement that aligns commercial incentives with clinical performance.

Comprehensive Research Methodology Outlining Data Collection Analysis Frameworks Validation Techniques and Quality Assurance for the Esomeprazole Magnesium Tablets Study

This research initiative integrates both primary and secondary data collection methodologies to ensure comprehensive coverage and rigorous validation. Primary research included in-depth interviews with key opinion leaders, formulary decision-makers, and senior executives across the value chain. Qualitative insights from these discussions were triangulated against secondary sources, such as peer-reviewed journals, regulatory filings, and industry white papers.

Quantitative analysis leveraged proprietary databases and structured modeling frameworks to assess cost structures, segmentation performance, and regional uptake patterns. A multi-layered quality assurance process, incorporating cross-functional review and statistical validation, underpins the research outputs to guarantee reliability and actionable insight.

Conclusive Insights Summarizing Strategic Imperatives Industry Outlook and Future Opportunities for Stakeholders in the Esomeprazole Magnesium Tablets Ecosystem

Through systematic examination of industry drivers, segmentation nuances, regional variations, and competitive tactics, this executive summary distills the strategic imperatives that will shape the esomeprazole magnesium enteric-coated tablets market in the coming years. Stakeholders must adopt a dynamic approach that aligns innovation, operational excellence, and stakeholder collaboration to maintain competitive advantage.

Looking ahead, patient-centric formulation enhancements, digital distribution models, and resilient supply chain designs will define success. By leveraging the insights presented, decision-makers can navigate regulatory complexities, optimize resource allocation, and capitalize on emerging opportunities within this critical therapeutic segment.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Gastroesophageal Reflux Disease
      • Erosive
      • Non Erosive
    • Peptic Ulcer Disease
      • Duodenal Ulcer
      • Gastric Ulcer
    • Zollinger Ellison Syndrome
  • Distribution Channel
    • Hospital Pharmacy
      • Private Hospital
      • Public Hospital
    • Online Pharmacy
      • E Commerce Platforms
      • Telepharmacy
    • Retail Pharmacy
      • Chain Pharmacy
      • Independent Pharmacy
  • Route Of Administration
    • Intravenous
    • Oral
  • Dosage Strength
    • 10 Mg
    • 20 Mg
    • 40 Mg
  • Dosage Form
    • Capsule
    • Tablet
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • AstraZeneca PLC
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Lupin Limited
  • Cipla Limited
  • Torrent Pharmaceuticals Ltd.
  • Zydus Lifesciences Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of precision dosing strategies based on CYP2C19 genetic profiling to optimize esomeprazole magnesium therapy
5.2. Development of long-acting enteric-coated tablet formulations enabling once-weekly esomeprazole dosing schedules
5.3. Integration of digital adherence monitoring platforms and smart packaging for esomeprazole therapy management
5.4. Surge in demand for pediatric esomeprazole magnesium granules with flavor-masked, age-appropriate formulations
5.5. Entry of biosimilar esomeprazole magnesium tablets intensifying price competition and formulary negotiations
5.6. Advancements in nanoparticle-based enteric coating technologies enhancing targeted delivery of esomeprazole
5.7. Novel co-formulations combining esomeprazole magnesium with prokinetic agents for enhanced GERD management
5.8. Regulatory updates on bioequivalence requirements for enteric-coated proton pump inhibitors altering market entry timelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Esomeprazole Magnesium Enteric-coated Tablets Market, by Application
8.1. Introduction
8.2. Gastroesophageal Reflux Disease
8.2.1. Erosive
8.2.2. Non Erosive
8.3. Peptic Ulcer Disease
8.3.1. Duodenal Ulcer
8.3.2. Gastric Ulcer
8.4. Zollinger Ellison Syndrome
9. Esomeprazole Magnesium Enteric-coated Tablets Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.2.1. Private Hospital
9.2.2. Public Hospital
9.3. Online Pharmacy
9.3.1. E Commerce Platforms
9.3.2. Telepharmacy
9.4. Retail Pharmacy
9.4.1. Chain Pharmacy
9.4.2. Independent Pharmacy
10. Esomeprazole Magnesium Enteric-coated Tablets Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
11. Esomeprazole Magnesium Enteric-coated Tablets Market, by Dosage Strength
11.1. Introduction
11.2. 10 Mg
11.3. 20 Mg
11.4. 40 Mg
12. Esomeprazole Magnesium Enteric-coated Tablets Market, by Dosage Form
12.1. Introduction
12.2. Capsule
12.3. Tablet
13. Americas Esomeprazole Magnesium Enteric-coated Tablets Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Esomeprazole Magnesium Enteric-coated Tablets Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Viatris Inc.
16.3.3. AstraZeneca PLC
16.3.4. Dr. Reddy’s Laboratories Ltd.
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Sandoz International GmbH
16.3.7. Lupin Limited
16.3.8. Cipla Limited
16.3.9. Torrent Pharmaceuticals Ltd.
16.3.10. Zydus Lifesciences Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHAI
FIGURE 26. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 27. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHCONTACTS
FIGURE 28. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY EROSIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY EROSIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY NON EROSIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY NON EROSIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ZOLLINGER ELLISON SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ZOLLINGER ELLISON SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TELEPHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TELEPHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 10 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 10 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 20 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 20 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 40 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 40 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 122. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 123. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 124. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 125. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 130. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 131. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 136. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 137. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 138. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 148. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 149. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 150. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 241. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 258. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Esomeprazole Magnesium Enteric-coated Tablets market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • AstraZeneca PLC
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Lupin Limited
  • Cipla Limited
  • Torrent Pharmaceuticals Ltd.
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Omeprazole Magnesium Enteric Coated Tablets Market by Product Type (OTC, Prescription), Indication (Erosive Esophagitis, Gastroesophageal Reflux Disease, Peptic Ulcer Disease), Strength, Distribution Channel, Packaging Type, End User - Global Forecast 2025-2030 - Product Image

Omeprazole Magnesium Enteric Coated Tablets Market by Product Type (OTC, Prescription), Indication (Erosive Esophagitis, Gastroesophageal Reflux Disease, Peptic Ulcer Disease), Strength, Distribution Channel, Packaging Type, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Esomeprazole Capsule Market by Application (Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Zollinger-Ellison Syndrome), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Dosage Strength, End User - Global Forecast 2025-2030 - Product Image

Esomeprazole Capsule Market by Application (Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Zollinger-Ellison Syndrome), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Dosage Strength, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Esomeprazole Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Image

Esomeprazole Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • 115 Pages
  • Global
From
Esomeprazole Market by Product Type (Branded, Generic), Formulation (Capsules, Oral Suspension, Tablets), Route of Administration, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Esomeprazole Market by Product Type (Branded, Generic), Formulation (Capsules, Oral Suspension, Tablets), Route of Administration, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Esomeprazole Magnesium Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Esomeprazole Magnesium Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 80 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.